1028 USTEKINUMAB IS ASSOCIATED WITH BETTER EFFECTIVENESS OUTCOMES WHEN COMPARED TO VEDOLIZUMAB IN CROHN'S DISEASE PATIENTS WITH PRIOR FAILURE TO ANTI-TNF: A COMPARATIVE EFFECTIVENESS STUDY FROM THE DUTCH ICC REGISTRY
2020
Keywords:
-
Correction
-
Source
-
Cite
-
Save
0
References
0
Citations
NaN
KQI